Research Shows Improved Brain Performance With Cognizin®
SALT LAKE CITY (June 21, 2012) - Healthy, middle-aged women taking supplements of citicoline, a naturally occurring brain health nutrient, saw improved attentional focus and inhibition, according to a peer-reviewed study conducted by University of Utah scientists. The study was published Wednesday in Food and Nutrition Sciences.
The double blind, placebo-controlled study composed of 60 healthy women between 40 and 60 years of age. After 28 days of citicoline administration, the study participants taking 250 mg indicated improved performance on cognitive function tests, and those taking 500 mg showed improvement and made significantly fewer errors on the tests compared to those in the placebo group.
"Our study findings indicate that citicoline supplementation was associated with improved attention focus and inhibition in a group of healthy female adult volunteers," according to the study's authors. "Prior research has shown that citicoline administration improved attention in a variety of patient populations, including those with cognitive deficits associated with illness or injury, but this study included only healthy, middle-aged women."
The study participants were divided into three groups; those taking a 250 mg dose and a 500 mg dose of citicoline under the brand name Cognizin®, and those taking a placebo.
"To our knowledge, this study is the first to examine the effects of low doses of citicoline on cognitive performance in healthy female adults," the authors concluded. "Practical applications of this research include the possible use of citicoline supplementation to improve cognitive deficits associated with normal aging, stress, and psychiatric disorders."
For more information about Cognizin, including a list of products and supplements that contain Cognizin citicoline, visit www.cognizin.com.
About Cognizin
Cognizin is a branded form of citicoline, a natural substance found in every cell of the body and especially vital to brain health.* Citicoline is broken down during intestinal absorption and, after passing through the blood/brain barrier, is reconstituted in the brain as citicoline.* Citicoline is a water-soluble compound that supplies precursors for the synthesis of phospholipids, including phosphatidyl-choline, a major constituent of brain tissue*; helps maintain normal levels of acetylcholine, a chemical that regulates memory and cognitive function*; enhances communication between neurons*; supports visual function*; protects neural structures from free radical damage*; enhances metabolism and healthy brain activity*; and helps sustain healthy cellular mitochondria for sustained energy*. Cognizin is also highly stable, GRAS, ultra-pure and allergen-free. For more information on Cognizin, visit www.cognizin.com. *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
About Kyowa Hakko USA
Kyowa Hakko is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa is the maker of branded ingredients including Cognizin® Citicoline, Lumistor® L-Hydroxyproline, Setria® Glutathione, Pantesin® Pantethine, as well as SustamineTM L-Alanyl-L-Glutamine.
Kyowa offers manufacturers and formulators one of the industry's most extensive lines of more than 50 amino acids and branch-chain amino acids, as well as nucleic acids, bio-products and fine chemicals.
###
Media Contact:
Ryann
Rasmussen, PR Counsel
Integrated Marketing Group
O:
(801) 538-0777 ext. 107
C:
(435) 327-1876